Cognito Therapeutics CEO Brent Vaughan to Speak at CODE Conference 2021
September 15, 2021
Cognito Therapeutics Announces Formation of Payor Advisory Board
September 8, 2021
How to grow a novel category in digital therapeutics – Everett Crossland and Andy Molnar
August 6, 2021
Cognito Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2021
August 4, 2021
‘Light Flash’ Treatment Might Help Slow Alzheimer’s
July 27, 2021
Alzheimer’s Association Annual Meeting Starts with Plenty of Exciting Data
July 26, 2021
AAIC21: Cognito’s gamma frequency neuromodulation reduces brain atrophy in Alzheimer’s trial
July 26, 2021
Cognito Therapeutics Presents New Clinical Data Demonstrating Disease-Modifying Effects of Gamma Frequency Neuro-modulation on Cognitive Function and Brain Atrophy in Alzheimer’s Disease at AAIC 2021
July 26, 2021
Advancing Breakthrough Treatments for a Novel Class of Neurodegenerative Targets in Alzheimer’s Disease
July 22, 2021
Our CEO Brent Vaughan will be joining an extraordinary lineup of life science leaders at CNS Summit, November 7-10 in Boston. Learn more